fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd

Updated on August 9, 2020

Stock/Share Code - SPARC

Sun Pharma Advanced Research Company is in the business of research & development of pharmaceutical products.

Below is the details of SPARC Sun Pharma Advanced Research Company Ltd

Market Cap₹3,594 Cr.
Current Price ₹178.55 as on 14 Aug 20
52 Week High / Low Price₹210.9 / ₹81
Face Value₹1
Stock P/E
Book Value₹5.32
Dividend Yield0.00 %
ROCE-61.22 %
ROE-61.76 %
Sales Growth (3yrs)4.28 %
SectorMiscellaneous
IndustryMiscellaneous
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company is expected to give good quarter Debtor days have improved from 60.21 to 20.30 days.
Cons: Stock is trading at 25.80 times its book value Company has low interest coverage ratio. The company has delivered a poor growth of 1.83% over past five years. Company has a low return on equity of -102.29% for last 3 years.

Sun Pharma Advanced Research Company Ltd Price Chart

Sun Pharma Advanced Research Company Ltd Price Chart

Sun Pharma Advanced Research Company Ltd Peer Comparison in Miscellaneous

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Gujarat Gas ₹313.75 15.56 ₹16,559.22 Cr. 0.42 ₹196.54 Cr. 30.57 18.36 2506.19 19.13
2. Multi Comm. Exc. ₹1.75 28.64 ₹6,773.06 Cr. 1.51 ₹65.5 Cr. 7.47 33.03 105.28 9.94
3. Security & Intel ₹26.5 25.01 ₹5,639.41 Cr. 0.52 -₹4.05 Cr. -105.58 13.04 2209.75 15.89
4. Affle India ₹2,103.15 59.94 ₹3,926.95 Cr. 0.00 ₹15.29 Cr. 5.67 32.29 80.02
5. SPARC ₹3,593.98 Cr. 0.00 -₹55.51 Cr. 19.57 -1.41 19.60 -61.22
6. ABB Power Produc ₹949.4 ₹3,463.64 Cr. 0.00 ₹29.18 Cr. 811.55
7. NESCO ₹518.65 12.98 ₹3,035.42 Cr. 0.70 ₹52.92 Cr. 3.06 25.92 117.75 23.16

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Sun Pharma Advanced Research Company Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019
Sales -422315192017612085171720
YOY Sales Growth %1.04%8.89%-83.81%-15.75%-51.71%-28.13%299.41%2.37%322.25%3.03%-71.98%-1.41%
Expenses -75101777865816790971128073
Material Cost %7%66%6%27%26%17%3%23%4%59%26%25%
Employee Cost %47%108%174%127%121%122%32%107%23%131%135%116%
Operating Profit-34-78-61-58-45-64-5-70-12-95-63-54
OPM %-81%-333%-400%-300%-224%-379%-8%-354%-14%-549%-366%-274%
Other Income4112501534421
Interest000000000100
Depreciation222222222222
Profit before tax-32-79-63-582-64-3-69-9-94-63-56
Tax %-0%-0%-0%-0%0%-0%-0%-0%-0%-0%-0%-0%
Net Profit-32-79-63-582-64-3-69-9-94-63-56
EPS in Rs-1.30-3.19-2.53-2.340.10-2.57-0.10-2.72-0.37-3.59-2.41-2.12
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -37353458298716715616118178183139
Sales Growth %-6%-2%70%-50%201%91%-7%4%12%-57%134%
Expenses -4145536599104134191224304321334363
Material Cost %18%22%20%13%26%11%5%6%12%14%34%7%
Manufacturing Cost %12%22%22%14%30%12%7%80%82%83%168%89%
Employee Cost %36%47%64%44%105%42%24%29%35%47%129%44%
Other Cost %44%39%49%41%181%55%44%7%11%25%79%42%
Operating Profit-3-10-19-7-70-1734-35-63-123-243-151-224
OPM %-9%-29%-56%-11%-241%-19%20%-23%-39%-68%-310%-83%-161%
Other Income0-00112103314541411
Interest0000046022001
Depreciation1233334788889
Profit before tax-5-12-22-8-72-2234-40-70-119-197-145-222
Tax %-7%27%-0%-0%-0%-0%12%-0%-0%-0%-0%-0%
Net Profit-5-9-22-8-72-2230-40-70-119-197-145-222
EPS in Rs0.000.000.000.000.000.001.230.000.000.000.000.00-8.49
Dividend Payout %-0%-0%-0%-0%-0%-0%0%-0%-0%-0%-0%-0%

Compounded Sales Growth

  • 10 Years:: 17.93%
  • 5 Years:: 1.83%
  • 3 Years:: 4.28%
  • TTM:: 17.62%

Compounded Profit Growth

  • TTM:: -21.71%

Return on Equity

  • 10 Years:: 4.84%
  • 5 Years:: -18.44%
  • 3 Years:: -23.28%
  • 1 Year:: -7.49%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital -21212121212424242425252626
Equity Capital20.7120.7120.7120.7120.7123.6623.6723.6723.6724.6925.0926.21
Reserves2415-7-15-8785116766133160270113
Borrowings0227688154563229
Other Liabilities -162456668420393977111122101124
Trade Payables87111016133027589410283108
Advance from Customers0124252520003330
Other liability items85331679121614161715
Total Liabilities6262727886209184143163273309398272
Fixed Assets -33536163646664677069525866
Gross Block3860717580858796107776780
Accumulated Depreciation571013161922303781523
CWIP142110101132432
Investments00020976001010821155
Other Assets -28491121461127692192146106119
Trade receivables241034252820939181020
Cash Equivalents0155677171370111
Loans n Advances4171827288946676349361
Other asset items-0-14-1512-14-12-8320795997
Total Assets6262727886209184143163273309398272

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity --2025132-69-9537-41-44-128-183-172
Profit from operations-3-10-18-6-69-1735-35-61-120-242-167
Receivables-2725-1-2-2-20-3811-30217
Payables101131107-317-331368-19
Loans Advances0000-5-4-4-13-16000
Direct taxes-0-0-0-0-1-1-8-3-14-21-10-5
Other operating items00000-5004474012
Cash from Investing Activity -20-26-12-8-2-994453-13-7-105-102
Fixed assets purchased-5-26-8-5-5-4-4-8-12-9-33-13
Fixed assets sold0000000010150
Investments purchased000-110-173-589-38-17-37-94-94
Investments sold000907768445172800
Interest received0000112411113
Inter corporate deposits000000-50500000
Other investing items240-4-11-0-0-0-2061
Cash from Financing Activity -010472194-81-151194224274
Proceeds from shares00000187100250133367
Proceeds from borrowings0124637831049000
Repayment of borrowings00-20-1-70-102-13000
Interest paid fin-0-0-0-0-0-1-9-0-2-3-0-0
Share application money0000110002000
Other financing items0000-10-10-1-5391-92
Net Cash Flow001-10-0-011-760-630

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %-10%-29%-79%-59%-1,034%-20%21%-32%-71%-95%-143%-61%
Debtor Days239551654105614721788220
Inventory Turnover

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Sun Pharma Advanced Research Company Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.